Overview
Nudge develops scalable brain interface technology using high-resolution ultrasound transducer arrays and phased array systems to enable precise brain circuit targeting for neuroscience research and biotechnology applications. The company's ultrasound-based approach provides a non-invasive method for neural stimulation and mapping, supporting advanced brain interface innovation across research and therapeutic domains.
More in Neurotechnology
Latest industry news
Butterfly Network's BCI Chip Licensing Deal Rattles Investors as Shares Drop Nearly 10%
2026-09-02 · Industry
Merge Labs and Butterfly Network Unite to Push Ultrasound-Based BCIs Into the Mainstream
2026-09-01 · Industry
FDA Grants CorTec Second Breakthrough Device Designation for Its Brain-Computer Interface
2026-08-31 · Policy
Aurenar Raises $5.7M to Bring Stroke Neuromodulation to the Recovery Room
2026-08-30 · Funding
Company details
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →